Long-term ritonavir exposure increases fatty acid and glycerol recycling in 3T3-L1 adipocytes as compensatory mechanisms for increased triacylglycerol hydrolysis

Endocrinology

Volumn 151, Issue 5, 2010, Pages 2097-2105

  Adler Wailes, Diane C ^a   Guiney, Evan L ^a   Wolins, Nathan E ^b   Yanovski, Jack A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLGLYCEROL; FATTY ACID; GLYCEROL; GLYCEROL KINASE; MESSENGER RNA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PYRUVIC ACID; RITONAVIR; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ENZYME INHIBITOR; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; ISOPRENALINE; TRIACSIN C; TRIAZENE DERIVATIVE;

ADIPOCYTE; ANIMAL CELL; ARTICLE; BIOSYNTHESIS; DOWN REGULATION; DRUG ACTIVITY; DRUG EXPOSURE; ESTERIFICATION; FATTY ACID TRANSPORT; GLYCERONEOGENESIS; HYDROLYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEADY STATE; UPREGULATION; ANIMAL; CELL STRAIN 3T3; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOBLOTTING; LIPODYSTROPHY; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME;

3T3-L1 CELLS; ADIPOCYTES; ADRENERGIC BETA-AGONISTS; ANIMALS; ENZYME INHIBITORS; FATTY ACIDS; GENE EXPRESSION; GLYCEROL; HIV PROTEASE INHIBITORS; HUMANS; HYDROLYSIS; IMMUNOBLOTTING; ISOPROTERENOL; LIPASE; LIPODYSTROPHY; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RITONAVIR; TIME FACTORS; TRIAZENES; TRIGLYCERIDES;

EID: 77953149956     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-1364     Document Type: Article

References (47)

1. Cadoudal T, Leroyer S, Reis AF, Tordjman J, Durant S, Fouque F, Collinet M, Quette J, Chauvet G, Beale E, Velho G, Antoine B, Benelli C, Forest C 2005 Proposed involvement of adipocyte glyceroneogenesis and phosphoenolpyruvate carboxykinase in the metabolic syndrome. Biochimie (Paris) 87:27-32
2. Prentki M, Madiraju SR 2008 Glycerolipid metabolism and signaling in health and disease. Endocr Rev 29:647-676
3. Arner P 2005 Human fat cell lipolysis: biochemistry, regulation and clinical role. Best Pract Res Clin Endocrinol Metab 19:471-482 (Pubitemid 41819214)
4. Kratz M, Purnell JQ, Breen PA, Thomas KK, Utzschneider KM, Carr DB, Kahn SE, Hughes JP, Rutledge EA, Van Yserloo B, Yukawa M, Weigle DS 2008 Reduced adipogenic gene expression in thigh adipose tissue precedes human immunodeficiency virus-associated lipoatrophy. J Clin Endocrinol Metab 93:959-966
5. Mallon PW 2007 Pathogenesis of lipodystrophy and lipid abnormalities in patients taking antiretroviral therapy. AIDS Rev 9:3-15 (Pubitemid 46730279)
6. van der Valk M, Bisschop PH, Romijn JA, Ackermans MT, Lange JM, Endert E, Reiss P, Sauerwein HP 2001 Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways. AIDS 15:2093-2100
7. van der Valk M, Reiss P, van Leth FC, Ackermans MT, Endert E, Romijn JA, Heijligenberg R, Sauerwein H 2002 Highly active antiretroviral therapy-induced lipodystrophy has minor effects on human immunodeficiency virus-induced changes in lipolysis, but normalizes resting energy expenditure. J Clin Endocrinol Metab 87:5066-5071
8. Vigouroux C, Gharakhanian S, Salhi Y, Nguyen TH, Chevenne D, Capeau J, Rozenbaum W 1999 Diabetes, insulin resistance and dyslipidaemia in lipodystrophic HIV-infected patients on highly active antiretroviral therapy (HAART). Diabetes Metab 25:225-232
9. Lagathu C, Eustace B, Prot M, Frantz D, Gu Y, Bastard JP, Maachi M, Azoulay S, Briggs M, Caron M, Capeau J 2007 Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages. Antivir Ther 12:489-500
10. Vernochet C, Azoulay S, Duval D, Guedj R, Cottrez F, Vidal H, Ailhaud G, Dani C 2005 Human immunodeficiency virus protease inhibitors accumulate into cultured human adipocytes and alter expression of adipocytokines. J Biol Chem 280:2238-2243
11. Dowell P, Flexner C, Kwiterovich PO, Lane MD 2000 Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors. J Biol Chem 275:41325-41332
12. Zhang B, MacNaul K, Szalkowski D, Li Z, Berger J, Moller DE 1999 Inhibition of adipocyte differentiation by HIV protease inhibitors. J Clin Endocrinol Metab 84:4274-4277 (Pubitemid 30644229)
13. Murata H, Hruz PW, Mueckler M 2000 The mechanism of insulin resistance caused by HIV protease inhibitor therapy. J Biol Chem 275:20251-20254
14. Adler-Wailes DC, Guiney EL, Koo J, Yanovski JA 2008 Effects of ritonavir on adipocyte gene expression: evidence for a stress-related response. Obesity (Silver Spring) 16:2379-2387
15. Parker RA, Flint OP, Mulvey R, Elosua C, Wang F, Fenderson W, Wang S, Yang WP, Noor MA 2005 Endoplasmic reticulum stress links dyslipidemia to inhibition of proteasome activity and glucose transport by HIV protease inhibitors. Mol Pharmacol 67:1909-1919
16. Adler-Wailes DC, Liu H, Ahmad F, Feng N, Londos C, Manganiello V, Yanovski JA 2005 Effects of the human immunodeficiency virus-protease inhibitor, ritonavir, on basal and catecholamine-stimulated lipolysis. J Clin Endocrinol Metab 90:3251-3261
17. Rudich A, Vanounou S, Riesenberg K, Porat M, Tirosh A, Harman-Boehm I, Greenberg AS, Schlaeffer F, Bashan N 2001 The HIV protease inhibitor nelfinavir induces insulin resistance and increases basal lipolysis in 3T3-L1 adipocytes. Diabetes 50:1425-1431
18. Frost SC, Lane MD 1985 Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes. J Biol Chem 260:2646-2652
19. Lewin TM, Kim JH, Granger DA, Vance JE, Coleman RA 2001 Acyl-CoA synthetase isoforms 1, 4, and 5 are present in different subcellular membranes in rat liver and can be inhibited independently. J Biol Chem 276:24674-24679
20. Listenberger LL, Ory DS, Schaffer JE 2001 Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J Biol Chem 276:14890-14895
21. Folch J, Lees M, Sloane Stanley GH 1957 A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497-509
22. Bradley DC, Kaslow HR 1989 Radiometric assays for glycerol, glucose, and glycogen. Anal Biochem 180:11-16
23. Tordjman J, Chauvet G, Quette J, Beale EG, Forest C, Antoine B 2003 Thiazolidinediones block fatty acid release by inducing glyceroneogenesis in fat cells. J Biol Chem 278:18785-18790
24. Miyoshi H, Perfield 2nd JW, Souza SC, Shen WJ, Zhang HH, Stancheva ZS, Kraemer FB, Obin MS, Greenberg AS 2007 Control of adipose triglyceride lipase action by serine 517 of perilipin A globally regulates protein kinase A-stimulated lipolysis in adipocytes. J Biol Chem 282:996-1002 (Pubitemid 47076543)
25. Brasaemle DL, Levin DM, Adler-Wailes DC, Londos C 2000 The lipolytic stimulation of 3T3-L1 adipocytes promotes the translocation of hormone-sensitive lipase to the surfaces of lipid storage droplets. Biochim Biophys Acta 1483:251-262
26. Downs TR, Wilfinger WW 1983 Fluorometric quantification of DNA in cells and tissue. Anal Biochem 131:538-547
27. Pfaffl MW 2001 A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45
28. Zimmermann R, Strauss JG, Haemmerle G, Schoiswohl G, Birner-Gruenberger R, Riederer M, Lass A, Neuberger G, Eisenhaber F, Hermetter A, Zechner R 2004 Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 306:1383-1386
29. Chen JL, Peacock E, Samady W, Turner SM, Neese RA, Hellerstein MK, Murphy EJ 2005 Physiologic and pharmacologic factors influencing glyceroneogenic contribution to triacylglyceride glycerol measured by mass isotopomer distribution analysis. J Biol Chem 280:25396-25402
30. Guan HP, Li Y, Jensen MV, Newgard CB, Steppan CM, Lazar MA 2002Afutile metabolic cycle activated in adipocytes by antidiabetic agents. Nat Med 8:1122-1128
31. Hanson RW, Reshef L 2003 Glyceroneogenesis revisited. Biochimie (Paris) 85:1199-1205
32. Hadigan C, Borgonha S, Rabe J, Young V, Grinspoon S 2002 Increased rates of lipolysis among human immunodeficiency virus-infected men receiving highly active antiretroviral therapy. Metabolism 51:1143-1147
33. Hadigan C, Rabe J, Meininger G, Aliabadi N, Breu J, Grinspoon S 2003 Inhibition of lipolysis improves insulin sensitivity in protease inhibitor-treated HIV-infected men with fat redistribution. Am J Clin Nutr 77:490-494 (Pubitemid 36133394)
34. Meininger G, Hadigan C, Laposata M, Brown J, Rabe J, Louca J, Aliabadi N, Grinspoon S 2002 Elevated concentrations of free fatty acids are associated with increased insulin response to standard glucose challenge in human immunodeficiency virus-infected subjects with fat redistribution. Metabolism 51:260-266
35. Villarroya F, Domingo P, Giralt M 2007 Lipodystrophy in HIV 1-infected patients: lessons for obesity research. Int J Obes (Lond) 31:1763-1776
36. Cianflone K, Zakarian R, Stanculescu C, Germinario R 2006 Protease inhibitor effects on triglyceride synthesis and adipokine secretion in human omental and subcutaneous adipose tissue. Antivir Ther 11:681-691
37. Zechner R, Kienesberger PC, Haemmerle G, Zimmermann R, Lass A 2009 Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores. J Lipid Res 50:3-21
38. Kershaw EE, Hamm JK, Verhagen LA, Peroni O, Katic M, Flier JS 2006 Adipose triglyceride lipase: function, regulation by insulin, and comparison with adiponutrin. Diabetes 55:148-157
39. Kovsan J, Ben-Romano R, Souza SC, Greenberg AS, Rudich A 2007 Regulation of adipocyte lipolysis by degradation of the perilipin protein: nelfinavir enhances lysosome-mediated perilipin proteolysis. J Biol Chem 282:21704-21711
40. Janneh O, Hoggard PG, Tjia JF, Jones SP, Khoo SH, Maher B, Back DJ, Pirmohamed M 2003 Intracellular disposition and metabolic effects of zidovudine, stavudine and four protease inhibitors in cultured adipocytes. Antivir Ther 8:417-426
41. Lenhard JM, Furfine ES, Jain RG, Ittoop O, Orband-Miller LA, Blanchard SG, Paulik MA, Weiel JE 2000 HIV protease inhibitors block adipogenesis and increase lipolysis in vitro. Antiviral Res 47:121-129
42. Beale EG, Hammer RE, Antoine B, Forest C 2004 Disregulated glyceroneogenesis: PCK1 as a candidate diabetes and obesity gene. Trends Endocrinol Metab 15:129-135 (Pubitemid 38445067)
43. Chakravarty K, Cassuto H, Reshef L, Hanson RW 2005 Factors that control the tissue-specific transcription of the gene for phosphoenolpyruvate carboxykinase-C. Crit Rev Biochem Mol Biol 40:129-154
44. Huq AH, Lovell RS, Ou CN, Beaudet AL, Craigen WJ 1997 X-linked glycerol kinase deficiency in the mouse leads to growth retardation, altered fat metabolism, autonomous glucocorticoid secretion and neonatal death. Hum Mol Genet 6:1803-1809
45. Olswang Y, Cohen H, Papo O, Cassuto H, Croniger CM, Hakimi P, Tilghman SM, Hanson RW, Reshef L 2002 A mutation in the peroxisome proliferator-activated receptor γ-binding site in the gene for the cytosolic form of phosphoenolpyruvate carboxykinase reduces adipose tissue size and fat content in mice. Proc Natl Acad Sci USA 99:625-630
46. Leroyer SN, Tordjman J, Chauvet G, Quette J, Chapron C, Forest C, Antoine B 2006 Rosiglitazone controls fatty acid cycling in human adipose tissue by means of glyceroneogenesis and glycerol phosphorylation. J Biol Chem 281:13141-13149
47. Grigem S, Fischer-Posovszky P, Debatin KM, Loizon E, Vidal H, Wabitsch M 2005 The effect of the HIV protease inhibitor ritonavir on proliferation, differentiation, lipogenesis, gene expression and apoptosis of human preadipocytes and adipocytes. Horm Metab Res 37:602-609